Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Transgene raises 65.5m Euros but Novartis opts-out

Authored by James Sheppard The BioValley based, French biopharmaceutical company, Transgene announced that it has raised a total of 65.5m Euros in a two-step capital increase. The first step was the completion of a rights issue, launched on Feb 28th … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , | Leave a comment

Gene Therapy Start-up AAVLife raises $12m

Authored by James Sheppard The Paris based biotechnology company, AAVLife announced that it had raised $12m in series A funding for its gene therapy assets. The funding round, led by Versant Ventures, will be used to advance a gene-deleting therapy … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

Roche purchases diagnostic company IQuum

Authored by James Sheppard The global pharmaceutical giant Roche announced that it completed the purchase of Boston biotech cluster based, diagnostics company IQuum. IQuum specialise in the development of point of care diagnostics (PoC) and will be absorbed into Roche’s … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Rare Disease biotech Aldeyra raises $25m in IPO

Authored by James Sheppard The Boston biotech cluster based company Aldeyra Therapeutics have raised $25m in an oversubscribed initial public offering (IPO). Aldeyra Therapeutics are developing treatments for rare skin and eye diseases. The clinical stage biotech company’s lead candidate … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , | Leave a comment

Swedish biotech Oxthera raises $10m for Orphan Drug Development

Authored by James Sheppard The Swedish biopharmaceutical company Oxthera announced that it had raised $10m from new and existing investors. The aim of the fundraising is to continue the clinical development programme for the company’s lead asset in primary hyperoxaluria. … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Sanofi appoint Chief Patient Officer

Authored by James Sheppard The French pharmaceutical giant Sanofi recently announced that it had appointed Dr Anne C. Beal as its new Chief Patient Officer. This is a new role within Sanofi and one that the company hopes will increase … Continue reading

Posted in Executive Appointments, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap